Department of Orthopaedic Surgery, Fukuoka University School of Medicine, Fukuoka, Japan.
J Orthop Surg Res. 2008 Dec 17;3:51. doi: 10.1186/1749-799X-3-51.
Hip fracture is associated with pronounced morbidity and excess mortality in elderly women with postmenopausal osteoporosis. Many drugs have been developed to treat osteoporosis and to reduce the risk of osteoporotic fractures. We investigated the effects of combined alendronate and vitamin D3 treatment on bone mass and fracture load at the femoral neck in ovariectomized (OVX) rats, and evaluated the relationship between bone mass parameters and femoral neck strength.
Thirty 12-week-old female rats underwent either a sham-operation (n = 6) or OVX (n = 24). Twenty weeks later, OVX rats were further divided into four groups and received daily doses of either saline alone, 0.1 mg/kg alendronate, 0.1 microg/kg calcitriol, or a combination of both two drugs by continuous infusion via Alzet mini-osmotic pumps. The sham-control group received saline alone. After 12 weeks of treatment, femoral necks were examined using peripheral quantitative computed tomography (pQCT) densitometry and mechanical testing.
Saline-treated OVX rats showed significant decreases in total bone mineral content (BMC) (by 28.1%), total bone mineral density (BMD) (by 9.5%), cortical BMC (by 26.3%), cancellous BMC (by 66.3%), cancellous BMD (by 29.0%) and total cross-sectional bone area (by 30.4%) compared with the sham-control group. The combined alendronate and calcitriol treatments improved bone loss owing to estrogen deficiency. On mechanical testing, although OVX significantly reduced bone strength of the femoral neck (by 29.3%) compared with the sham-control group, only the combined treatment significantly improved the fracture load at the femoral neck in OVX rats to the level of the sham-controls. The correlation of total BMC to fracture load was significant, but that of total BMD was not.
Our results showed that the combined treatment with alendronate and calcitriol significantly improved bone fragility of the femoral neck in OVX osteopenic rats.
绝经后骨质疏松症老年女性髋部骨折与明显的发病率和死亡率增加有关。已经开发了许多药物来治疗骨质疏松症和降低骨质疏松性骨折的风险。我们研究了联合使用阿伦膦酸盐和维生素 D3 治疗对去卵巢(OVX)大鼠股骨颈骨量和骨折负荷的影响,并评估了骨量参数与股骨颈强度之间的关系。
30 只 12 周龄雌性大鼠行假手术(n = 6)或 OVX(n = 24)。20 周后,OVX 大鼠进一步分为四组,通过 Alzet 迷你渗透泵持续输注,每天分别给予生理盐水、0.1mg/kg 阿伦膦酸盐、0.1μg/kg 骨化三醇或两种药物的联合剂量。假手术对照组给予生理盐水。治疗 12 周后,使用外周定量计算机断层扫描(pQCT)密度仪和机械测试检查股骨颈。
与假手术对照组相比,生理盐水处理的 OVX 大鼠总骨矿物质含量(BMC)(减少 28.1%)、总骨矿物质密度(BMD)(减少 9.5%)、皮质 BMC(减少 26.3%)、松质 BMC(减少 66.3%)、松质 BMD(减少 29.0%)和总横截面积(减少 30.4%)均显著降低。联合使用阿伦膦酸盐和骨化三醇治疗可改善因雌激素缺乏引起的骨丢失。在机械测试中,尽管 OVX 大鼠与假手术对照组相比,股骨颈骨强度显著降低(降低 29.3%),但仅联合治疗可显著提高 OVX 大鼠股骨颈的骨折负荷,使其达到假手术对照组的水平。总 BMC 与骨折负荷的相关性显著,但总 BMD 无相关性。
我们的研究结果表明,联合使用阿伦膦酸盐和骨化三醇可显著改善 OVX 骨质疏松大鼠股骨颈的脆性。